Stock 6160 BEIGENE, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart BeiGene, Ltd. Hong Kong S.E.

Equities

6160

KYG1146Y1017

Delayed Hong Kong S.E.
Other stock markets
 12:07:50 28/05/2024 pm IST 		5-day change 1st Jan Change
91.9 HKD -0.70% Intraday chart for BeiGene, Ltd. -8.74% -16.53%
24/05 BeiGene Says Studies Highlight Effectiveness, Safety of Lymphoma Drug Brukinsa MT
24/05 BeiGene, Ltd. Announces New Analyses for BRUKINSA® (zanubrutinib) At ASCO Underscore Differentiated Clinical Profile for Treatment of CLL and SLL CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
BEIGENE, LTD.
Bio Therapeutic Drugs
-0.70%-8.74%-16.53%-33.45%+19.20% 15.97B - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. BGNE Stock
  4. 6160 Stock
  5. Charts BeiGene, Ltd.
  6. Comparison Chart